Effects of insulin-like growth factor-I on cultured human coronary artery smooth muscle cells

Antoni Bayes-Genis, Robert S. Schwartz, Laurie K. Bale, Cheryl A Conover

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The growth-promoting effects of insulin-like growth factor-I (IGF-I) appear to be different in vascular smooth muscle cells from various segments of the arterial tree. Little information exists on human coronary artery smooth muscle cells (CoSMC), the primary elements of coronary atherosclerosis and post-angioplasty restenosis. In this study we determined the effects of IGF-I on cultured human CoSMC. Type I IGF receptors (IGF-R) were present on CoSMC as assessed by affinity cross-linking of 125I-IGF-I to monolayer cultures. IGF-I was a weak mitogen, 1.5-fold increase in [3H]thymidine incorporation, for CoSMC. However, IGF-I had a potent motility effect on CoSMC with a 314 ± 12% increase in cell migration (P < 0.001), comparable to that of 5% FBS. IGF-I-stimulated motility was partially inhibited by αIR-3, a specific IGF-R inhibitor (P < 0.05). Addition of kistrin, a disintegrin, or LM609, a specific αvβ3 integrin neutralizing antibody, abolished IGF-I-stimulated migration (P < 0.001). This study indicates that IGF-I is a potent motility agent for human CoSMC via the αvβ3 integrin receptor, but exerts little mitogenic effect. Because CoSMC migration plays a crucial role in atherosclerosis and restenosis, IGF-I blockade has the potential to limit lumen reduction.

Original languageEnglish (US)
Pages (from-to)246-253
Number of pages8
JournalGrowth Hormone and IGF Research
Volume13
Issue number5
DOIs
StatePublished - Oct 2003

Fingerprint

Insulin-Like Growth Factor I
Smooth Muscle Myocytes
Coronary Vessels
Integrins
Cell Movement
Disintegrins
IGF Type 1 Receptor
Neutralizing Antibodies
Vascular Smooth Muscle
Mitogens
Angioplasty
Thymidine
Coronary Artery Disease
Atherosclerosis
Growth

Keywords

  • IGF-I
  • Migration
  • Vascular smooth muscle cells

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Effects of insulin-like growth factor-I on cultured human coronary artery smooth muscle cells. / Bayes-Genis, Antoni; Schwartz, Robert S.; Bale, Laurie K.; Conover, Cheryl A.

In: Growth Hormone and IGF Research, Vol. 13, No. 5, 10.2003, p. 246-253.

Research output: Contribution to journalArticle

Bayes-Genis, Antoni ; Schwartz, Robert S. ; Bale, Laurie K. ; Conover, Cheryl A. / Effects of insulin-like growth factor-I on cultured human coronary artery smooth muscle cells. In: Growth Hormone and IGF Research. 2003 ; Vol. 13, No. 5. pp. 246-253.
@article{b3d458a59abd41b3964553309cf0a010,
title = "Effects of insulin-like growth factor-I on cultured human coronary artery smooth muscle cells",
abstract = "The growth-promoting effects of insulin-like growth factor-I (IGF-I) appear to be different in vascular smooth muscle cells from various segments of the arterial tree. Little information exists on human coronary artery smooth muscle cells (CoSMC), the primary elements of coronary atherosclerosis and post-angioplasty restenosis. In this study we determined the effects of IGF-I on cultured human CoSMC. Type I IGF receptors (IGF-R) were present on CoSMC as assessed by affinity cross-linking of 125I-IGF-I to monolayer cultures. IGF-I was a weak mitogen, 1.5-fold increase in [3H]thymidine incorporation, for CoSMC. However, IGF-I had a potent motility effect on CoSMC with a 314 ± 12{\%} increase in cell migration (P < 0.001), comparable to that of 5{\%} FBS. IGF-I-stimulated motility was partially inhibited by αIR-3, a specific IGF-R inhibitor (P < 0.05). Addition of kistrin, a disintegrin, or LM609, a specific αvβ3 integrin neutralizing antibody, abolished IGF-I-stimulated migration (P < 0.001). This study indicates that IGF-I is a potent motility agent for human CoSMC via the αvβ3 integrin receptor, but exerts little mitogenic effect. Because CoSMC migration plays a crucial role in atherosclerosis and restenosis, IGF-I blockade has the potential to limit lumen reduction.",
keywords = "IGF-I, Migration, Vascular smooth muscle cells",
author = "Antoni Bayes-Genis and Schwartz, {Robert S.} and Bale, {Laurie K.} and Conover, {Cheryl A}",
year = "2003",
month = "10",
doi = "10.1016/S1096-6374(03)00013-3",
language = "English (US)",
volume = "13",
pages = "246--253",
journal = "Endocrinology and Metabolism, Supplement",
issn = "1096-6374",
publisher = "Churchill Livingstone",
number = "5",

}

TY - JOUR

T1 - Effects of insulin-like growth factor-I on cultured human coronary artery smooth muscle cells

AU - Bayes-Genis, Antoni

AU - Schwartz, Robert S.

AU - Bale, Laurie K.

AU - Conover, Cheryl A

PY - 2003/10

Y1 - 2003/10

N2 - The growth-promoting effects of insulin-like growth factor-I (IGF-I) appear to be different in vascular smooth muscle cells from various segments of the arterial tree. Little information exists on human coronary artery smooth muscle cells (CoSMC), the primary elements of coronary atherosclerosis and post-angioplasty restenosis. In this study we determined the effects of IGF-I on cultured human CoSMC. Type I IGF receptors (IGF-R) were present on CoSMC as assessed by affinity cross-linking of 125I-IGF-I to monolayer cultures. IGF-I was a weak mitogen, 1.5-fold increase in [3H]thymidine incorporation, for CoSMC. However, IGF-I had a potent motility effect on CoSMC with a 314 ± 12% increase in cell migration (P < 0.001), comparable to that of 5% FBS. IGF-I-stimulated motility was partially inhibited by αIR-3, a specific IGF-R inhibitor (P < 0.05). Addition of kistrin, a disintegrin, or LM609, a specific αvβ3 integrin neutralizing antibody, abolished IGF-I-stimulated migration (P < 0.001). This study indicates that IGF-I is a potent motility agent for human CoSMC via the αvβ3 integrin receptor, but exerts little mitogenic effect. Because CoSMC migration plays a crucial role in atherosclerosis and restenosis, IGF-I blockade has the potential to limit lumen reduction.

AB - The growth-promoting effects of insulin-like growth factor-I (IGF-I) appear to be different in vascular smooth muscle cells from various segments of the arterial tree. Little information exists on human coronary artery smooth muscle cells (CoSMC), the primary elements of coronary atherosclerosis and post-angioplasty restenosis. In this study we determined the effects of IGF-I on cultured human CoSMC. Type I IGF receptors (IGF-R) were present on CoSMC as assessed by affinity cross-linking of 125I-IGF-I to monolayer cultures. IGF-I was a weak mitogen, 1.5-fold increase in [3H]thymidine incorporation, for CoSMC. However, IGF-I had a potent motility effect on CoSMC with a 314 ± 12% increase in cell migration (P < 0.001), comparable to that of 5% FBS. IGF-I-stimulated motility was partially inhibited by αIR-3, a specific IGF-R inhibitor (P < 0.05). Addition of kistrin, a disintegrin, or LM609, a specific αvβ3 integrin neutralizing antibody, abolished IGF-I-stimulated migration (P < 0.001). This study indicates that IGF-I is a potent motility agent for human CoSMC via the αvβ3 integrin receptor, but exerts little mitogenic effect. Because CoSMC migration plays a crucial role in atherosclerosis and restenosis, IGF-I blockade has the potential to limit lumen reduction.

KW - IGF-I

KW - Migration

KW - Vascular smooth muscle cells

UR - http://www.scopus.com/inward/record.url?scp=0141854293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141854293&partnerID=8YFLogxK

U2 - 10.1016/S1096-6374(03)00013-3

DO - 10.1016/S1096-6374(03)00013-3

M3 - Article

C2 - 12932745

AN - SCOPUS:0141854293

VL - 13

SP - 246

EP - 253

JO - Endocrinology and Metabolism, Supplement

JF - Endocrinology and Metabolism, Supplement

SN - 1096-6374

IS - 5

ER -